spire healthcare group plc on wednesday outlined its longterm financial objectives including a 5 compound annual growth rate plus inflationrelated increases in addition the uk private healthcare company forecast more than 50 million pounds 609 million of additional revenue from new services and an earnings before interest taxes depreciation and amortization margin in excess of 21 spire said organic capital expenditure will be 67 of revenue and expects to restore the dividend in 2023 with a policy of paying 2535 of profit after tax subject to leverage ratios shares at 0759 gmt were down 15 at 2335 pence